102
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Timing of onset of cognitive decline: results from Whitehall II prospective cohort study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objectives To estimate 10 year decline in cognitive function from longitudinal data in a middle aged cohort and to examine whether age cohorts can be compared with cross sectional data to infer the effect of age on cognitive decline.

          Design Prospective cohort study. At study inception in 1985-8, there were 10 308 participants, representing a recruitment rate of 73%.

          Setting Civil service departments in London, United Kingdom.

          Participants 5198 men and 2192 women, aged 45-70 at the beginning of cognitive testing in 1997-9.

          Main outcome measure Tests of memory, reasoning, vocabulary, and phonemic and semantic fluency, assessed three times over 10 years.

          Results All cognitive scores, except vocabulary, declined in all five age categories (age 45-49, 50-54, 55-59, 60-64, and 65-70 at baseline), with evidence of faster decline in older people. In men, the 10 year decline, shown as change/range of test×100, in reasoning was −3.6% (95% confidence interval −4.1% to −3.0%) in those aged 45-49 at baseline and −9.6% (−10.6% to −8.6%) in those aged 65-70. In women, the corresponding decline was −3.6% (−4.6% to −2.7%) and −7.4% (−9.1% to −5.7%). Comparisons of longitudinal and cross sectional effects of age suggest that the latter overestimate decline in women because of cohort differences in education. For example, in women aged 45-49 the longitudinal analysis showed reasoning to have declined by −3.6% (−4.5% to −2.8%) but the cross sectional effects suggested a decline of −11.4% (−14.0% to −8.9%).

          Conclusions Cognitive decline is already evident in middle age (age 45-49).

          Related collections

          Most cited references20

          • Record: found
          • Abstract: not found
          • Article: not found

          The cohort as a concept in the study of social change.

          N B Ryder (1965)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Heritability estimates versus large environmental effects: the IQ paradox resolved.

            Some argue that the high heritability of IQ renders purely environmental explanations for large IQ differences between groups implausible. Yet, large environmentally induced IQ gains between generations suggest an important role for environment in shaping IQ. The authors present a formal model of the process determining IQ in which people's IQs are affected by both environment and genes, but in which their environments are matched to their IQs. The authors show how such a model allows very large effects for environment, even incorporating the highest estimates of heritability. Besides resolving the paradox, the authors show that the model can account for a number of other phenomena, some of which are anomalous when viewed from the standard perspective.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Vascular risk factors and dementia: how to move forward?

              In recent years, accumulating evidence has suggested that vascular risk factors contribute to Alzheimer disease (AD). Vascular dementia had been traditionally considered secondary to stroke and vascular disease. It has been traditionally distinguished from AD, considered to be a purely neurodegenerative form of dementia. However, in light of this more recent literature, it appears that there is a spectrum: ranging from patients with pure vascular dementia to patients with pure AD and including a large majority of patients with contributions from both Alzheimer and vascular pathologies. In this article, we discuss the impact of vascular risk factors on AD and its consequences at the individual level and at the population level by highlighting the concept of attributable risk. We then discuss the key questions and next steps involved in designing a therapeutic trial to control vascular risk factors for the prevention of dementia.
                Bookmark

                Author and article information

                Contributors
                Role: research director
                Role: professor of social epidemiology
                Role: assistant professor
                Role: research director
                Role: research director
                Role: professor of old age psychiatry
                Role: senior research fellow
                Role: statistician
                Journal
                BMJ
                bmj
                BMJ : British Medical Journal
                BMJ Publishing Group Ltd.
                0959-8138
                1468-5833
                2012
                2012
                05 January 2012
                : 344
                : d7622
                Affiliations
                [1 ]Institut National de la Santé et de la Recherche Médicale (INSERM), U1018, Centre for Research in Epidemiology and Population Health, Hôpital Paul Brousse, 94807 Villejuif Cedex, France
                [2 ]Department of Epidemiology and Public Health, University College London, London, UK
                [3 ]Centre de Gérontologie, Hôpital Ste Périne, AP-HP, France
                [4 ]Department of Society, Human Development, and Health, Harvard School of Public Health, Boston, MA, USA
                [5 ]Institut National de la Santé et de la Recherche Médicale (INSERM), U708, F-75013, Paris, France
                [6 ]UPMC Univ Paris 06, UMR_S 708, F-75005, Paris
                [7 ]Institut National de la Santé et de la Recherche Médicale (INSERM) U1061 Université Montpellier 1, Montpellier, France
                [8 ]CMRR Languedoc-Roussillon, CHU Montpellier
                [9 ]Oxford University Department of Psychiatry, Warneford Hospital, Oxford, UK
                [10 ]University of Bristol, Bristol, UK
                Author notes
                Correspondence to: A Singh-Manoux, INSERM, U1018, Centre for Research in Epidemiology and Population Health, Hôpital Paul Brousse, Bât 15/16, 16 Avenue Paul Vaillant Couturier, 94807 Villejuif Cedex, France Archana.Singh-Manoux@ 123456inserm.fr
                Article
                sina874776
                10.1136/bmj.d7622
                3281313
                22223828
                0c2c4918-f959-4266-b49e-f6acd9865cbc
                © Singh-Manoux et al 2012

                This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.

                History
                : 26 October 2011
                Categories
                Research

                Medicine
                Medicine

                Comments

                Comment on this article